Therapeutic spectrum of interferon‐β in ischemic stroke
Identifieur interne : 000974 ( Ncbi/Merge ); précédent : 000973; suivant : 000975Therapeutic spectrum of interferon‐β in ischemic stroke
Auteurs : Madhuri Wanve ; Harpreet Kaur ; Deepaneeta Sarmah ; Jackson Saraf ; Kanta Pravalika ; Kanchan Vats ; Kiran Kalia ; Anupom Borah ; Dileep R. Yavagal ; Kunjan R. Dave ; Pallab BhattacharyaSource :
- Journal of Neuroscience Research [ 0360-4012 ] ; 2018.
Abstract
Ischemic stroke is devastating and a major cause of morbidity and mortality worldwide. To date, only clot retrieval devices and/or intravenous tissue plasminogen activators (tPA) have been approved by the US‐FDA for the treatment of acute ischemic stroke. Therefore, there is an urgent need to develop an effective treatment for stroke that can have limited shortcomings and broad spectrum of applications. Interferon‐beta (IFN‐β), an endogenous cytokine and a key anti‐inflammatory agent, contributes toward obviating deleterious stroke outcomes. Therefore, exploring the role of IFN‐β may be a promising alternative approach for stroke intervention in the future. In the present review, we have discussed about IFN‐β along with its different mechanistic roles in ischemic stroke. Furthermore, therapeutic approaches targeting the inflammatory cascade with IFN‐β therapy that may be helpful in improving stroke outcome are also discussed.
Url:
DOI: 10.1002/jnr.24333
PubMed: 30320448
PubMed Central: 7167007
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000952
- to stream Pmc, to step Curation: 000952
- to stream Pmc, to step Checkpoint: 000728
Links to Exploration step
PMC:7167007Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Therapeutic spectrum of interferon‐β in ischemic stroke</title><author><name sortKey="Wanve, Madhuri" sort="Wanve, Madhuri" uniqKey="Wanve M" first="Madhuri" last="Wanve">Madhuri Wanve</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Kaur, Harpreet" sort="Kaur, Harpreet" uniqKey="Kaur H" first="Harpreet" last="Kaur">Harpreet Kaur</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Sarmah, Deepaneeta" sort="Sarmah, Deepaneeta" uniqKey="Sarmah D" first="Deepaneeta" last="Sarmah">Deepaneeta Sarmah</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Saraf, Jackson" sort="Saraf, Jackson" uniqKey="Saraf J" first="Jackson" last="Saraf">Jackson Saraf</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Pravalika, Kanta" sort="Pravalika, Kanta" uniqKey="Pravalika K" first="Kanta" last="Pravalika">Kanta Pravalika</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Vats, Kanchan" sort="Vats, Kanchan" uniqKey="Vats K" first="Kanchan" last="Vats">Kanchan Vats</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Kalia, Kiran" sort="Kalia, Kiran" uniqKey="Kalia K" first="Kiran" last="Kalia">Kiran Kalia</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Borah, Anupom" sort="Borah, Anupom" uniqKey="Borah A" first="Anupom" last="Borah">Anupom Borah</name><affiliation><nlm:aff id="jnr24333-aff-0002"></nlm:aff></affiliation></author><author><name sortKey="Yavagal, Dileep R" sort="Yavagal, Dileep R" uniqKey="Yavagal D" first="Dileep R." last="Yavagal">Dileep R. Yavagal</name><affiliation><nlm:aff id="jnr24333-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Dave, Kunjan R" sort="Dave, Kunjan R" uniqKey="Dave K" first="Kunjan R." last="Dave">Kunjan R. Dave</name><affiliation><nlm:aff id="jnr24333-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Bhattacharya, Pallab" sort="Bhattacharya, Pallab" uniqKey="Bhattacharya P" first="Pallab" last="Bhattacharya">Pallab Bhattacharya</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">30320448</idno><idno type="pmc">7167007</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167007</idno><idno type="RBID">PMC:7167007</idno><idno type="doi">10.1002/jnr.24333</idno><date when="2018">2018</date><idno type="wicri:Area/Pmc/Corpus">000952</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000952</idno><idno type="wicri:Area/Pmc/Curation">000952</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000952</idno><idno type="wicri:Area/Pmc/Checkpoint">000728</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000728</idno><idno type="wicri:Area/Ncbi/Merge">000974</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Therapeutic spectrum of interferon‐β in ischemic stroke</title><author><name sortKey="Wanve, Madhuri" sort="Wanve, Madhuri" uniqKey="Wanve M" first="Madhuri" last="Wanve">Madhuri Wanve</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Kaur, Harpreet" sort="Kaur, Harpreet" uniqKey="Kaur H" first="Harpreet" last="Kaur">Harpreet Kaur</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Sarmah, Deepaneeta" sort="Sarmah, Deepaneeta" uniqKey="Sarmah D" first="Deepaneeta" last="Sarmah">Deepaneeta Sarmah</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Saraf, Jackson" sort="Saraf, Jackson" uniqKey="Saraf J" first="Jackson" last="Saraf">Jackson Saraf</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Pravalika, Kanta" sort="Pravalika, Kanta" uniqKey="Pravalika K" first="Kanta" last="Pravalika">Kanta Pravalika</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Vats, Kanchan" sort="Vats, Kanchan" uniqKey="Vats K" first="Kanchan" last="Vats">Kanchan Vats</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Kalia, Kiran" sort="Kalia, Kiran" uniqKey="Kalia K" first="Kiran" last="Kalia">Kiran Kalia</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author><author><name sortKey="Borah, Anupom" sort="Borah, Anupom" uniqKey="Borah A" first="Anupom" last="Borah">Anupom Borah</name><affiliation><nlm:aff id="jnr24333-aff-0002"></nlm:aff></affiliation></author><author><name sortKey="Yavagal, Dileep R" sort="Yavagal, Dileep R" uniqKey="Yavagal D" first="Dileep R." last="Yavagal">Dileep R. Yavagal</name><affiliation><nlm:aff id="jnr24333-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Dave, Kunjan R" sort="Dave, Kunjan R" uniqKey="Dave K" first="Kunjan R." last="Dave">Kunjan R. Dave</name><affiliation><nlm:aff id="jnr24333-aff-0003"></nlm:aff></affiliation></author><author><name sortKey="Bhattacharya, Pallab" sort="Bhattacharya, Pallab" uniqKey="Bhattacharya P" first="Pallab" last="Bhattacharya">Pallab Bhattacharya</name><affiliation><nlm:aff id="jnr24333-aff-0001"></nlm:aff></affiliation></author></analytic><series><title level="j">Journal of Neuroscience Research</title><idno type="ISSN">0360-4012</idno><idno type="eISSN">1097-4547</idno><imprint><date when="2018">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>Abstract</title><p>Ischemic stroke is devastating and a major cause of morbidity and mortality worldwide. To date, only clot retrieval devices and/or intravenous tissue plasminogen activators (tPA) have been approved by the US‐FDA for the treatment of acute ischemic stroke. Therefore, there is an urgent need to develop an effective treatment for stroke that can have limited shortcomings and broad spectrum of applications. Interferon‐beta (IFN‐β), an endogenous cytokine and a key anti‐inflammatory agent, contributes toward obviating deleterious stroke outcomes. Therefore, exploring the role of IFN‐β may be a promising alternative approach for stroke intervention in the future. In the present review, we have discussed about IFN‐β along with its different mechanistic roles in ischemic stroke. Furthermore, therapeutic approaches targeting the inflammatory cascade with IFN‐β therapy that may be helpful in improving stroke outcome are also discussed.</p></div></front><back><div1 type="bibliography"><listBibl><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurosci Res</journal-id><journal-id journal-id-type="iso-abbrev">J. Neurosci. Res</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1097-4547</journal-id><journal-id journal-id-type="publisher-id">JNR</journal-id><journal-title-group><journal-title>Journal of Neuroscience Research</journal-title></journal-title-group><issn pub-type="ppub">0360-4012</issn><issn pub-type="epub">1097-4547</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30320448</article-id><article-id pub-id-type="pmc">7167007</article-id><article-id pub-id-type="doi">10.1002/jnr.24333</article-id><article-id pub-id-type="publisher-id">JNR24333</article-id><article-categories><subj-group subj-group-type="overline"><subject>Minireview</subject></subj-group><subj-group subj-group-type="heading"><subject>Minireviews</subject></subj-group></article-categories><title-group><article-title>Therapeutic spectrum of interferon‐β in ischemic stroke</article-title><alt-title alt-title-type="right-running-head">XXXX</alt-title><alt-title alt-title-type="left-running-head">Wanve et al.</alt-title></title-group><contrib-group><contrib id="jnr24333-cr-0001" contrib-type="author"><name><surname>Wanve</surname><given-names>Madhuri</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0002" contrib-type="author"><name><surname>Kaur</surname><given-names>Harpreet</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0003" contrib-type="author"><name><surname>Sarmah</surname><given-names>Deepaneeta</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0004" contrib-type="author"><name><surname>Saraf</surname><given-names>Jackson</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0005" contrib-type="author"><name><surname>Pravalika</surname><given-names>Kanta</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0006" contrib-type="author"><name><surname>Vats</surname><given-names>Kanchan</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0007" contrib-type="author"><name><surname>Kalia</surname><given-names>Kiran</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref></contrib><contrib id="jnr24333-cr-0008" contrib-type="author"><name><surname>Borah</surname><given-names>Anupom</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0002"><sup>2</sup></xref></contrib><contrib id="jnr24333-cr-0009" contrib-type="author"><name><surname>Yavagal</surname><given-names>Dileep R.</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0003"><sup>3</sup></xref></contrib><contrib id="jnr24333-cr-0010" contrib-type="author"><name><surname>Dave</surname><given-names>Kunjan R.</given-names></name><xref ref-type="aff" rid="jnr24333-aff-0003"><sup>3</sup></xref></contrib><contrib id="jnr24333-cr-0011" contrib-type="author" corresp="yes"><name><surname>Bhattacharya</surname><given-names>Pallab</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2867-1650</contrib-id><xref ref-type="aff" rid="jnr24333-aff-0001"><sup>1</sup></xref><address><email>pallab.bhu@gmail.com</email><email>pallab.bhattacharya@niperahm.ac.in</email></address></contrib></contrib-group><aff id="jnr24333-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">Department of Pharmacology and Toxicology</named-content><institution>National Institute of Pharmaceutical Education and Research (NIPER)</institution><city>Gandhinagar</city><country country="IN">India</country></aff><aff id="jnr24333-aff-0002"><label><sup>2</sup></label><named-content content-type="organisation-division">Cellular and Molecular Neurobiology Laboratory, Department of Life Science and Bioinformatics</named-content><institution>Assam University</institution><city>Silchar</city><country country="IN">India</country></aff><aff id="jnr24333-aff-0003"><label><sup>3</sup></label><named-content content-type="organisation-division">Department of Neurology and Neurosurgery</named-content><institution>University of Miami Miller School of Medicine</institution><city>Miami</city><named-content content-type="country-part">Florida</named-content></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>Pallab Bhattacharya, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Palaj, Gandhinagar 382355, Gujarat, India.<break></break>Email: <email>pallab.bhu@gmail.com</email>; <email>pallab.bhattacharya@niperahm.ac.in</email><break></break></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="ppub"><month>2</month><year>2019</year></pub-date><volume>97</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/jnr.v97.2</issue-id><fpage>116</fpage><lpage>127</lpage><history><date date-type="received"><day>14</day><month>6</month><year>2018</year></date><date date-type="rev-recd"><day>05</day><month>9</month><year>2018</year></date><date date-type="accepted"><day>05</day><month>9</month><year>2018</year></date></history><permissions><pmc-comment> © 2019 Wiley Periodicals, Inc. </pmc-comment>
<copyright-statement content-type="article-copyright">© 2018 Wiley Periodicals, Inc</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:JNR-97-116.pdf"></self-uri><abstract id="jnr24333-abs-0001"><title>Abstract</title><p>Ischemic stroke is devastating and a major cause of morbidity and mortality worldwide. To date, only clot retrieval devices and/or intravenous tissue plasminogen activators (tPA) have been approved by the US‐FDA for the treatment of acute ischemic stroke. Therefore, there is an urgent need to develop an effective treatment for stroke that can have limited shortcomings and broad spectrum of applications. Interferon‐beta (IFN‐β), an endogenous cytokine and a key anti‐inflammatory agent, contributes toward obviating deleterious stroke outcomes. Therefore, exploring the role of IFN‐β may be a promising alternative approach for stroke intervention in the future. In the present review, we have discussed about IFN‐β along with its different mechanistic roles in ischemic stroke. Furthermore, therapeutic approaches targeting the inflammatory cascade with IFN‐β therapy that may be helpful in improving stroke outcome are also discussed.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jnr24333-kwd-0004">Anti‐inflammatory</kwd><kwd id="jnr24333-kwd-0003">cytokines</kwd><kwd id="jnr24333-kwd-0002">IFN‐β</kwd><kwd id="jnr24333-kwd-0001">stroke</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Science and Engineering Research Board </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001843</institution-id></institution-wrap></funding-source><award-id>SB/YS/LS-196/2014</award-id></award-group><award-group id="funding-0002"><funding-source>NIPER‐Ahmedabad</funding-source></award-group><award-group id="funding-0003"><funding-source>Department of Pharmaceuticals, Ministry of Chemical and Fertilizers</funding-source></award-group><award-group id="funding-0004"><funding-source><institution-wrap><institution>International Society for Neurochemistry </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100008992</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="3"></fig-count><table-count count="2"></table-count><page-count count="0"></page-count><word-count count="22336"></word-count></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2019</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.0 mode:remove_FC converted:15.04.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation"><mixed-citation publication-type="journal" id="jnr24333-cit-1001"><string-name><surname>Wanve</surname><given-names>M</given-names></string-name>, <string-name><surname>Kaur</surname><given-names>H</given-names></string-name>, <string-name><surname>Sarmah</surname><given-names>D</given-names></string-name>, et al. <article-title>Therapeutic spectrum of interferon‐β in ischemic stroke</article-title>. <source xml:lang="en">J Neuro Res</source>. <year>2019</year>;<volume>97</volume>:<fpage>116</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.24333</pub-id></mixed-citation></p><fn-group><fn id="jnr24333-note-0001"><p><bold>Funding Information</bold> Science and Engineering Research Board, Grant/Award Number: SB/YS/LS‐196/2014; NIPER‐Ahmedabad; Department of Pharmaceuticals, Ministry of Chemical
and Fertilizers; International Society for Neurochemistry</p></fn></fn-group></notes></front></pmc><affiliations><list></list><tree><noCountry><name sortKey="Bhattacharya, Pallab" sort="Bhattacharya, Pallab" uniqKey="Bhattacharya P" first="Pallab" last="Bhattacharya">Pallab Bhattacharya</name><name sortKey="Borah, Anupom" sort="Borah, Anupom" uniqKey="Borah A" first="Anupom" last="Borah">Anupom Borah</name><name sortKey="Dave, Kunjan R" sort="Dave, Kunjan R" uniqKey="Dave K" first="Kunjan R." last="Dave">Kunjan R. Dave</name><name sortKey="Kalia, Kiran" sort="Kalia, Kiran" uniqKey="Kalia K" first="Kiran" last="Kalia">Kiran Kalia</name><name sortKey="Kaur, Harpreet" sort="Kaur, Harpreet" uniqKey="Kaur H" first="Harpreet" last="Kaur">Harpreet Kaur</name><name sortKey="Pravalika, Kanta" sort="Pravalika, Kanta" uniqKey="Pravalika K" first="Kanta" last="Pravalika">Kanta Pravalika</name><name sortKey="Saraf, Jackson" sort="Saraf, Jackson" uniqKey="Saraf J" first="Jackson" last="Saraf">Jackson Saraf</name><name sortKey="Sarmah, Deepaneeta" sort="Sarmah, Deepaneeta" uniqKey="Sarmah D" first="Deepaneeta" last="Sarmah">Deepaneeta Sarmah</name><name sortKey="Vats, Kanchan" sort="Vats, Kanchan" uniqKey="Vats K" first="Kanchan" last="Vats">Kanchan Vats</name><name sortKey="Wanve, Madhuri" sort="Wanve, Madhuri" uniqKey="Wanve M" first="Madhuri" last="Wanve">Madhuri Wanve</name><name sortKey="Yavagal, Dileep R" sort="Yavagal, Dileep R" uniqKey="Yavagal D" first="Dileep R." last="Yavagal">Dileep R. Yavagal</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000974 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000974 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= PMC:7167007
|texte= Therapeutic spectrum of interferon‐β in ischemic stroke
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:30320448" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a StressCovidV1
| This area was generated with Dilib version V0.6.33. |  |